Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingping Cao

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Cell Reports|June 30, 2021
Structural basis for sterol sensing by Scap and InsigRenhong Yan, Pingping Cao, Wenqi Song, et al.
Genes|April 23, 2022
Full-Length Transcriptome Analysis of the Halophyte <i>Nitraria sibirica</i> PallHuilong Zhang, Zhen Liu, Aishuang Hu, et al.
European Journal of Pharmacology|August 23, 2021
The neuroprotective effect of phillyrin in intracerebral hemorrhagic mice is produced by activation of the Nrf2 signaling pathwayXin Guo, Pingping Cao, Xiongfeng Lian, et al.
Molecular Cancer Research : MCR|December 4, 2023
TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/β-Catenin SignalingXianglin Zuo, Xuchun Wang, Tingzheng Ma, et al.
Life Sciences|January 29, 2026
A protective role of ECSIT in chemotherapy-induced intestinal mucositis by maintaining Lgr5<sup>+</sup> intestinal stem cells and gut homeostasisShuai Wang, Yuying Jiang, Jie Yu, et al.
Molecular Cancer Research : MCR|September 18, 2021
Heritable Variants in the Chromosome <i>1q22</i> Locus Increase Gastric Cancer Risk via Altered Chromatin Looping and Increased UBAP2L ExpressionWei Guan, Nan Yang, Xianglin Zuo, et al.
International Immunopharmacology|April 8, 2022
Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia/reperfusion injury via regulating MAPK/NF-κB signalingBeilei Chen, Pingping Cao, Xin Guo, et al.
Cell Communication and Signaling : CCS|April 11, 2023
Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancerYufeng Li, Tianyu Mao, Jing Wang, et al.
Chemical Society Reviews|March 13, 2025
Breaking symmetry for better catalysis: insights into single-atom catalyst designPingping Cao, Xueqin Mu, Fanjiao Chen, et al.
Medcomm|March 11, 2024
Genome-scale CRISPR-Cas9 screen identifies <i>PAICS</i> as a therapeutic target for <i>EGFR</i> wild-type non-small cell lung cancerYufeng Li, Lingyun Zhu, Jiaqi Mao, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Cell Reports|June 30, 2021
Structural basis for sterol sensing by Scap and InsigRenhong Yan, Pingping Cao, Wenqi Song, et al.
Genes|April 23, 2022
Full-Length Transcriptome Analysis of the Halophyte <i>Nitraria sibirica</i> PallHuilong Zhang, Zhen Liu, Aishuang Hu, et al.
European Journal of Pharmacology|August 23, 2021
The neuroprotective effect of phillyrin in intracerebral hemorrhagic mice is produced by activation of the Nrf2 signaling pathwayXin Guo, Pingping Cao, Xiongfeng Lian, et al.
Molecular Cancer Research : MCR|December 4, 2023
TNFRSF19 within the 13q12.12 Risk Locus Functions as a Lung Cancer Suppressor by Binding Wnt3a to Inhibit Wnt/β-Catenin SignalingXianglin Zuo, Xuchun Wang, Tingzheng Ma, et al.
Life Sciences|January 29, 2026
A protective role of ECSIT in chemotherapy-induced intestinal mucositis by maintaining Lgr5<sup>+</sup> intestinal stem cells and gut homeostasisShuai Wang, Yuying Jiang, Jie Yu, et al.
Molecular Cancer Research : MCR|September 18, 2021
Heritable Variants in the Chromosome <i>1q22</i> Locus Increase Gastric Cancer Risk via Altered Chromatin Looping and Increased UBAP2L ExpressionWei Guan, Nan Yang, Xianglin Zuo, et al.
International Immunopharmacology|April 8, 2022
Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia/reperfusion injury via regulating MAPK/NF-κB signalingBeilei Chen, Pingping Cao, Xin Guo, et al.
Cell Communication and Signaling : CCS|April 11, 2023
Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancerYufeng Li, Tianyu Mao, Jing Wang, et al.
Chemical Society Reviews|March 13, 2025
Breaking symmetry for better catalysis: insights into single-atom catalyst designPingping Cao, Xueqin Mu, Fanjiao Chen, et al.
Medcomm|March 11, 2024
Genome-scale CRISPR-Cas9 screen identifies <i>PAICS</i> as a therapeutic target for <i>EGFR</i> wild-type non-small cell lung cancerYufeng Li, Lingyun Zhu, Jiaqi Mao, et al.
Pageof 4